Stock ABEO ABEONA THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
4.38 USD +4.04% Intraday chart for Abeona Therapeutics Inc. +7.88% -12.57%
May. 30 Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target MT
May. 16 Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO
PR
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO
PR
Abeona Therapeutics: Q1 Earnings Snapshot
AQ
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO
PR
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
AQ
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
AQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
BU
Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
BU
The Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
BU
Abeona Therapeutics Provides Regulatory Update on Pz-cel
AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
AQ
Abeona Therapeutics Announces New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABEO Stock
  4. News Abeona Therapeutics Inc.
  5. Press Releases